Champions Oncology Inc
NASDAQ:CSBR

Watchlist Manager
Champions Oncology Inc Logo
Champions Oncology Inc
NASDAQ:CSBR
Watchlist
Price: 8.82 USD -0.79% Market Closed
Market Cap: 122m USD

Wall Street
Price Targets

CSBR Price Targets Summary
Champions Oncology Inc

Wall Street analysts forecast CSBR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSBR is 12.24 USD with a low forecast of 12.12 USD and a high forecast of 12.6 USD.

Lowest
Price Target
12.12 USD
37% Upside
Average
Price Target
12.24 USD
39% Upside
Highest
Price Target
12.6 USD
43% Upside
Champions Oncology Inc Competitors:
Price Targets
BICO
BICO Group AB
75% Upside
FLB
Fluidigm Corp
104% Upside
QNTPF
XtalPi Holdings Ltd
104% Upside
CGEN
Compugen Ltd
260% Upside
SAILIFE
Sai Life Sciences Ltd
6% Upside
BIOT
Biotage AB
3% Upside
TECN
Tecan Group AG
28% Upside
300463
Maccura Biotechnology Co Ltd
15% Upside

Revenue
Forecast

Revenue Estimate
Champions Oncology Inc

For the last 8 years the compound annual growth rate for Champions Oncology Inc's revenue is 21%. The projected CAGR for the next 4 years is 18%.

21%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Champions Oncology Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss

Net Income
Forecast

Net Income Estimate
Champions Oncology Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CSBR's stock price target?
Price Target
12.24 USD

According to Wall Street analysts, the average 1-year price target for CSBR is 12.24 USD with a low forecast of 12.12 USD and a high forecast of 12.6 USD.

What is Champions Oncology Inc's Revenue forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Champions Oncology Inc's revenue is 21%. The projected CAGR for the next 4 years is 18%.

Back to Top